Medicine & Health

Long-term use of a new drug, toferson, approved by the FDA for a rare genetic form of ALS, delays symptom progression and death and leads to stabilization or improvement in some patients, according to a study by WashU Medicine researchers and collaborators.

Researchers at Washington University in St. Louis have found a way to better track circadian brain signals that synchronize the body clocks.

ShiNung Ching, an expert in neuroengineering, has been named chair of the Preston M. Green Department of Electrical & Systems Engineering at the McKelvey School of Engineering.

WashU Medicine researchers show that psychedelic compounds such as psilocybin appear to distort the link between blood flow and brain-cell functioning, which scientists use to track brain activity.

Researchers at WashU Medicine Mallinckrodt Institute of Radiology have received a $5 million grant from the National Institutes of Health (NIH) to study how patterns of brain aging and degeneration mirror early-life experiences.

Meaghan Creed, an associate professor of anesthesiology at WashU Medicine, has received a $3.3 million five-year grant from the National Institute on Drug Abuse to study dopamine system changes underlying depression symptoms in people with chronic neuropathic pain.

A group of researchers from Washington University in St. Louis has created a new kind of fiber-optic device to manipulate neural activity deep in the brain.

Christopher D. Smyser, MD, a renowned pediatric neurologist specializing in neonatal neurology and infant brain development, has been appointed director of the Division of Pediatric & Developmental Neurology in the Department of Neurology at WashU Medicine.

A new study by WashU researchers showed that family fights and peer bullying outweighed other risk factors for depression and other mental health problems, with adolescent girls suffering more than boys.

Using advanced biophysical and imaging techniques, Meredith Jackrel and her team at Washington University in St. Louis have isolated the protein Matrin-3 to better understand its role in neurodegenerative diseases.